logo en
  • Home
  • Manufacturing
    • Manufacturing
    • OEM Manufacturing
    • Quality Control
  • About the Factory
    • About the Factory
    • Our History
    • Management
    • Certificates
    • Partners
    • Licenses
    • Achievements
    • Special Evaluation of Labour Conditions
    • Videos
  • News
  • Products
  • Contacts
    • Contacts
    • Quality Claims
  • 简体中文(中国)
  • Russian (Russia)
  • You are here:  
  • Home /
  • News

News

Medsintez Plant Took Second Place in the Production Standards and Occupational Safety Competition

Details
Published: 10 November 2026
Medsintez Plant was recognized as a winner of the Sverdlovsk Region's Production Standards and Occupational Safety Competition for 2025, taking second place in the Chemical and Petrochemical Industry category. A total of 65 regional companies participated in the competition organized by the Department of Labor and Employment of the Sverdlovsk Region.

Read more ...

Medsintez Plant Implements a Project under Professionalitet Federal Programme

Details
Published: 10 November 2026
Medsintez Plant, one of Russia's largest vertically integrated pharmaceutical companies, has supported the launch of a new educational track at the Novouralsk College of Technology under the federal professional education programme—Professionalitet. The initiative is the result of a socially significant cooperation between the Medsintez plant, local educational institutions, and the Government of the Sverdlovsk Region. The company will invest 8 million rubles in the project.

Read more ...

National Pharmaceutical Security is the Work of the Youth: Medsintez Plant at the International Youth Festival

Details
Published: 21 September 2026

On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto "Follow Your Dream," the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.

Read more ...

TRIAZAVIRIN® Included in the New Clinical Guidelines of the Ministry of Health of the Russian Federation for Treatment of ARVI in Children

Details
Published: 18 September 2026

The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.

Read more ...

Medsintez Plant Showcases Diabetes and Infertility Drugs at the 2nd Regional Endocrinological Congress in Nizhny Novgorod

Details
Published: 14 September 2026

On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.

Read more ...

Page 1 of 23

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Privacy Policy

Copyright © 2003-2026

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts

Для использования сайта дайте согласие на обработку файлов cookie и ваших персональных данных, в т.ч. с помощью сервиса «Яндекс Метрика», в соответствии с Политикой по обработке персональных данных путем нажатия на кнопку «Ок»